Abstract
Immunological factors are important in pathogenesis of various malignancies, including neural cancers. The CXC chemokine CXCL12 is involved in the immune responses. Therefore, the aim of the present study was to investigate the association between tumor tissue and circulating concentrations of CXCL12 as well as its genetic variation at position +801 known as(the SDF-1 3'A), in Iranian patients suffering from malignant glial tumors. In this study, stereotactic tumor biopsy specimens in parallel with peripheral blood samples were collected from 123 patients and 189 healthy controls. The serum level of CXCL12 was measured by ELISA and tumor tissues were subjected to Western blotting for intra-tumor CXCL12 detection; we also employed PCR-RFLP to detect the SDF-1 3'A polymorphism. Demographic data were collected by a researcher-designed questionnaire. These results demonstrated a significant difference between the A/A, A/G, and G/G genotype and A and G alleles of polymorphisms at position +801 of CXCL12. We also indicated elevated levels of CXCL12 in circulation and tumor tissue obtained from in patients suffering from malignant glial tumors. Based upon the results of this investigation, we propose that CXCL12 and its SDF-1 3'A polymorphism play a fundamental part in the pathogenesis of malignant glial tumors. It is also noteworthy that CXCL12 could probably be utilized as a beneficial biological marker in the diagnosis of these tumors.
Similar content being viewed by others
References
Azin H, Vazirinejad R, Ahmadabadi BN, Khorramdelazad H, Zarandi ER, Arababadi MK et al (2011) The SDF-1 3'A genetic variation of the chemokine SDF-1alpha (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients. J Mol Neurosci 29:29
Bajetto A, Bonavia R, Barbero S, Piccioli P, Costa A, Florio T et al (1999) Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J Neurochem 73(6):2348–2357
Bajetto A, Bonavia R, Barbero S, Florio T, Schettini G (2001a) Chemokines and their receptors in the central nervous system. Front Neuroendocrinol 22(3):147–184
Bajetto A, Barbero S, Bonavia R, Piccioli P, Pirani P, Florio T et al (2001b) Stromal cell-derived factor-1alpha induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway. J Neurochem 77(5):1226–1236
Bajetto A, Bonavia R, Barbero S, Schettini G (2002) Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J Neurochem 82(6):1311–1329
Barbero S, Bajetto A, Bonavia R, Porcile C, Piccioli P, Pirani P et al (2002) Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro. Ann N Y Acad Sci 973:60–69
Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL et al (2003) Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 63(8):1969–1974
Burger JA, Peled A (2009) CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia 23(1):43–52, Epub 2008 Nov 6
Busillo JM, Benovic JL (2007) Regulation of CXCR4 signaling. Biochim Biophys Acta 1768(4):952–963, Epub 2006 Nov 10
Christopherson K 2nd, Hromas R (2001) Chemokine regulation of normal and pathologic immune responses. Stem Cells 19(5):388–396
Ehtesham M, Winston JA, Kabos P, Thompson RC (2006) CXCR4 expression mediates glioma cell invasiveness. Oncogene 25(19):2801–2806
Fulton AM (2009) The chemokine receptors CXCR4 and CXCR3 in cancer. Curr Oncol Rep 11(2):125–131
Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A et al (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21(21):2683–2710
Gonzalo JA, Lloyd CM, Peled A, Delaney T, Coyle AJ, Gutierrez-Ramos JC (2000) Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease. J Immunol 165(1):499–508
Hess DC, Borlongan CV (2008) Cell-based therapy in ischemic stroke. Expert Rev Neurother 8(8):1193–1201
Kantele JM, Kurk S, Jutila MA (2000) Effects of continuous exposure to stromal cell-derived factor-1 alpha on T cell rolling and tight adhesion to monolayers of activated endothelial cells. J Immunol 164(10):5035–5040
Leonardi A (2002) Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res 21(3):319–339
Li M, Ransohoff RM (2008) Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol 84(2):116–131, Epub 2007 Nov 26
Loetscher P, Gong JH, Dewald B, Baggiolini M, Clark-Lewis I (1998) N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. J Biol Chem 273(35):22279–22283
Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK et al (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15(11):1311–1333
Nanki T, Lipsky PE (2000) Cutting edge: stromal cell-derived factor-1 is a costimulator for CD4+ T cell activation. J Immunol 164(10):5010–5014
Oh JW, Drabik K, Kutsch O, Choi C, Tousson A, Benveniste EN (2001) CXC chemokine receptor 4 expression and function in human astroglioma cells. J Immunol 166(4):2695–2704
Pedeboscq S, L'Azou B, Liguoro D, Pometan JP, Cambar J (2007) Interindividual differences in anticancer drug cytotoxicity in primary human glioblastoma cells. Exp Toxicol Pathol 58(4):247–253, Epub 2006 Nov 22
Peng SB, Peek V, Zhai Y, Paul DC, Lou Q, Xia X et al (2005) Akt activation, but not extracellular signal-regulated kinase activation, is required for SDF-1alpha/CXCR4-mediated migration of epitheloid carcinoma cells. Mol Cancer Res 3(4):227–236
Redjal N, Chan JA, Segal RA, Kung AL (2006) CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas. Clin Cancer Res 12(22):6765–6771
Rempel SA, Dudas S, Ge S, Gutierrez JA (2000) Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 6(1):102–111
Robinson DS, Hamid Q, Jacobson M, Ying S, Kay AB, Durham SR (1993) Evidence for Th2-type T helper cell control of allergic disease in vivo. Springer Semin Immunopathol 15(1):17–27
Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K et al (2003) A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci U S A 100(23):13513–13518, Epub 2003 Oct 31
Sehgal A, Keener C, Boynton AL, Warrick J, Murphy GP (1998a) CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells. J Surg Oncol 69(2):99–104
Sehgal A, Ricks S, Boynton AL, Warrick J, Murphy GP (1998b) Molecular characterization of CXCR-4: a potential brain tumor-associated gene. J Surg Oncol 69(4):239–248
Sozzani S, Luini W, Borsatti A, Polentarutti N, Zhou D, Piemonti L et al (1997) Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol 159(4):1993–2000
Stevenson CB, Ehtesham M, McMillan KM, Valadez JG, Edgeworth ML, Price RR et al (2008) CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities. Neurosurgery 63(3):560–569, discussion 9–70
Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359(5):492–507
Xie K (2001) Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 12(4):375–391
Zhou Y, Larsen PH, Hao C, Yong VW (2002) CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 277(51):49481–49487, Epub 2002 Oct 17
Acknowledgments
The authors thank all patients and healthy controls who participated in this research program. This project was financially supported by a grant from the Rafsanjan University of Medical Sciences.
Conflicts of interest
The authors of this declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moosavi, S.R., Khorramdelazad, H., Amin, M. et al. The SDF-1 3'A Genetic Variation Is Correlated with Elevated Intra-tumor Tissue and Circulating Concentration of CXCL12 in Glial Tumors. J Mol Neurosci 50, 298–304 (2013). https://doi.org/10.1007/s12031-013-9954-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-013-9954-2